Skip to content

Immediate antidepressant response of oral ketamine versus IV ketamine in depression

Comparison of acute antidepressant response of IV Ketamine versus oral Ketamine in treatment resistant depression

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027644
Enrollment
60
Registered
2020-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F322- Major depressive disorder, singleepisode, severe without psychotic features

Interventions

Intervention1: Oral ketamine: oral dose of 2.0â??2.5 mg/kg ketamine will be administered on day 0, day 3, day 5, day 7, day 9, day 11 and day 13 Control Intervention1: Intravenous ketamine 0.5 mg/kg:

Sponsors

Dr P N Suresh Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Failed 2 trial of different antidepressant class of adequate dose and duration. 2 Current depressive episode is of at least 4 weeks duration. 3 Not received ECT at least prior to enrollment.

Exclusion criteria

Exclusion criteria: 1 Other psychiatric disorders. 2 Pregnancy and lactation. 3 Concurrent major life-threatening illness like malignancy, cardiac failure, renal failure etc. 4 Alcohol and substance abuse and smokers. 5 Patients with electrocardiogram abnormality or abnormality on fundoscopy.

Design outcomes

Primary

MeasureTime frame
change in clinical ratings of depression in Hamilton Depression Rating ScaleTimepoint: Day 0,3,5,7,9,11,13

Secondary

MeasureTime frame
Changes in Montgomery Asberg Depression rating scale and Clinical Global Impression of severity and ImprovementTimepoint: Day 0,3,5,7,9,11,13 and 1 month

Countries

India

Contacts

Public ContactDrPNSuresh Kumar MD DPM DNB PhD MRC Psych

IQRAA Psychiatric care and rehabilitation centre

drpnsuresh@gmail.com04952379246

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026